Methyl 5-cyclopropyl-1H-pyrazole-4-carboxylate, 95.0%, 1g

N-methyl-N-phenyl-beta-alanine, 95.0%, 1g

Tert-butyl (5-bromo-2-methoxyphenyl)carbamate, 98%, 10g

4-Ethylbenzenesulfonamide>98.0%(HPLC)(N)25g

(S)-Methyl 3-hydroxy-2-methylpropanoate, 95.0%, 100g

Trial kit Spectra/Por® Biotech CE, 100–500 dalton(s), 1 Piece(s)

3-Benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one, 98%, 100mg

1-(4-Iodophenoxy)-3,5-dimethylbenzene, 98%, 1g

Oxetane-3-carbaldehyde, 95.0%, 25g

2-Thiopheneacetyl chloride, 98.0%, 5g

2-Amino-3-(7-fluoro-1H-indol-3-yl)propanoic acid, 97.0%, 1g

(2R,3S,5R)-5-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 97%, 100mg

5-Bromo-2-methoxypyridin-4-amine, 95.0%, 1g